Blog
RSS FeedPosted by Michael Wonder on 27 Jul 2023
Molnupiravir will remain available for people who need it
27 July 2023 - PHARMAC has confirmed today that molnupiravir will remain available as a treatment to protect against infection ...
Posted by Michael Wonder on 24 Jul 2023
Shingles can be deadly, so why is the vaccine only free for one year of life?
25 July 2023 - One in three people are at risk of developing shingles in their lifetime and the risk increases ...
Posted by Michael Wonder on 20 Jul 2023
PHARMAC joins international collaboration to advance use of health technology assessments
20 July 2023 - PHARMAC has joined an international collaboration of government health technology assessment agencies. ...
Posted by Michael Wonder on 01 Jul 2023
New Zealand Pharmaceutical Schedule - 1 July 2023
1 July 2023 - The July 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 23 Jun 2023
PHARMAC publishes minutes from February 2023 PTAC meeting
21 June 2023 - The meeting was held on 16-17 February 2023 in person and via Zoom. ...
Posted by Michael Wonder on 22 Jun 2023
PHARMAC considers widening access to treatments for multiple sclerosis and haemophilia A
22 June 2023 - PHARMAC has started a consultation today for widening access for two treatments; ocrelizumab (Ocrevus) as the first ...
Posted by Michael Wonder on 09 Jun 2023
PHARMAC breast cancer cost saving proposal welcome but ignores patients facing “dead-end”
8 June 2023 - Breast Cancer Foundation NZ is urging PHARMAC to widen access to an already funded treatment for ...
Posted by Michael Wonder on 08 Jun 2023
Proposal to widen access to intravenous trastuzumab and change the funded brand
8 June 2023 - The proposal would also give more New Zealanders funded access to intravenous trastuzumab. ...
Posted by Michael Wonder on 07 Jun 2023
PHARMAC confirms funding of rituximab for IgG4 related disease
7 June 2023 - PHARMAC has published a notification for widened access to rituximab (Riximyo) for people with the chronic inflammatory ...
Posted by Michael Wonder on 07 Jun 2023
Mid-life women being let down by PHARMAC, say menopause experts
6 June 2023 - New Zealand women in mid-life are being let down by Pharmac, say two doctors specialising in ...
Posted by Michael Wonder on 31 May 2023
New Zealand Pharmaceutical Schedule - 1 June 2023
1 June 2023 - The June 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 29 May 2023
Consultation for various vaccine supply agreements
29 May 2023 - PHARMAC is consulting on potential new supply agreements for multiple vaccines listed in the National Immunisation Schedule. ...
Posted by Michael Wonder on 18 May 2023
Helping with health costs: prescription charge scrapped, providing cheaper medicine
18 May 2023 - The Chris Hipkins Government is reducing the cost of health care for New Zealand households by ...
Posted by Michael Wonder on 14 May 2023
'Would they run out of Viagra?' PHARMAC slammed for huge shortage of HRT
15 May 2023 - Northland women going through menopause are starting to suffer from a raft of “horrible” symptoms caused ...
Posted by Michael Wonder on 11 May 2023
Ovarian cancer: Bay of Plenty mother spends more than $130,000 on treatments
12 May 2023 - Four cancer treatments in three years: $132,775. ...